Latest Kidney Problems: Misc. news
ASN: Empagliflozin Cuts Risk for Progression in CKD
posted November 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
CKD Incidence Differs by Race in People With Diabetes
posted November 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Second, Third COVID-19 Vaccine May Up Relapse in Glomerular Disease
posted November 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Dapagliflozin May Be Cost-Effective for Treating CKD
posted November 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Early Complications Common in Older Kidney Transplant Recipients .jpeg)
1997 to 2022 Saw Increase in Pediatric Hospitalizations With AKI 
Frailty Linked to Incident Cognitive Decline in Men With CKD Monthly Specialist Briefings
Stay Connected
